CEO SUMMARY: An examination of recent earnings reports from the top global in vitro diagnostics (IVD) companies uncovers three macro-trends that clinical laboratories should monitor. Among those trends are continuing pressure from China’s volume-based procurement reforms, a milder-than-expected demand for respiratory testing earlier this year, and the war in Iran. Expect IVD firms to attempt […]
What Earnings Calls Reveal about Shifting IVD Pipelines
China’s policies and a milder respiratory season cut into bottom lines
- By Mark Terry
- > From the Volume XXXIII, No. 9 - July, 2026 Issue
